McDermott advises Servier as Part of the Agreement with Taiho Pharmaceutical Co., Ltd.

Overview


Emmanuelle Trombe and Nicholas Lafont advised French pharmaceutical company Servier on its exclusive license agreement with Taiho Pharmaceutical Co., Ltd. of Japan to develop and market TAS-102 (an anti-cancer drug administered orally) in Europe and in other countries.